Lewicki John A.
Chief Scientific Officer at MREO; President & CEO at OncoMed Pharmaceuticals Inc
- Sold, on record
- $2M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Sep 13, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MREOMereo BioPharma Group plcChief Scientific Officer
- OncoMed Pharmaceuticals IncPresident & CEO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- OncoMed Pharmaceuticals Inc96,348 shares
- MREO40,373 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedApr 4 2017
Sold 5,754 shares at $9.06 ($52k)
Lewicki John A., EVP, Research & Development
Sold 20.1% of holdings ($260k position)22,937 shares left0.6x usual sizeFiling
- 2 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedOct 10 +189 days
Sold 1,248 shares at $4.24 ($5k)
Lewicki John A., EVP, Research & Development
Sold 1.7% of holdings ($304k position)70,412 shares left0.2x usual sizeFiling
- 3 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedApr 24 +196 days
Sold 4,557 shares at $2.68 ($12k)
Lewicki John A., President & CEO
Sold 7.6% of holdings ($161k position)55,418 shares left0.8x usual sizeFiling
- 4 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedOct 9 +168 days
Sold 2,296 shares at $2.13 ($5k)
Lewicki John A., President & CEO
Sold 3.9% of holdings ($127k position)57,122 shares left0.4x usual sizeFiling
- 5 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedOct 10 +1 day
Sold 1,156 shares at $2.01 ($2k)
Lewicki John A., President & CEO
Sold 2% of holdings ($115k position)55,966 shares left0.3x usual sizeFiling
- 6 Form 144 notice MREONoticeJun 20 +2080 days
Filed to sell 26,647 shares ($106k)
Lewicki John A., Officer
No 10b5-1 planFirst sale on recordFiling
- 7 Form 4 sale MREOUnusualJun 26 +6 days
Sold 24,224 shares at $3.48 ($84k)
Lewicki John A., Chief Scientific Officer
No 10b5-1 planSold 33.2% of holdings ($254k position)48,779 shares leftFirst sale on recordFollows a Form 144Filing
- 8 Form 4 sale MREONo planSep 13 +79 days
Sold 16,149 shares at $4.30 ($69k)
Lewicki John A., Chief Scientific Officer
No 10b5-1 planSold 17% of holdings ($408k position)78,630 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (21)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | MREO | Chief Scientific Officer | Form 4 sale | 16,149 | $69k | 17.0% | No plan | SEC |
| Jun 26, 2024 | MREO | Chief Scientific Officer | Form 4 sale | 24,224 | $84k | 33.2% | Unusual | SEC |
| Jun 20, 2024 | MREO | Officer | Form 144 notice | 26,647 | $106k | Notice | SEC | |
| Oct 10, 2018 | OncoMed Pharmaceuticals Inc | President & CEO | Form 4 sale | 1,156 | $2k | 2.0% | Plan not stated | SEC |
| Oct 9, 2018 | OncoMed Pharmaceuticals Inc | President & CEO | Form 4 sale | 2,296 | $5k | 3.9% | Plan not stated | SEC |
| Apr 24, 2018 | OncoMed Pharmaceuticals Inc | President & CEO | Form 4 sale | 4,557 | $12k | 7.6% | Plan not stated | SEC |
| Oct 10, 2017 | OncoMed Pharmaceuticals Inc | EVP, Research & Development | Form 4 sale | 1,248 | $5k | 1.7% | Plan not stated | SEC |
| Apr 4, 2017 | OncoMed Pharmaceuticals Inc | EVP, Research & Development | Form 4 sale | 5,754 | $52k | 20.1% | Plan not stated | SEC |
| Jan 3, 2017 | OncoMed Pharmaceuticals Inc | EVP, Research & Development | Form 4 sale | 9,175 | $70k | 22.5% | Plan not stated | SEC |
| Jan 7, 2016 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 2,162 | $48k | 10.8% | Plan not stated | SEC |
| Jun 16, 2015 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 17,000 | $426k | 45.9% | Unusual | SEC |
| Apr 2, 2015 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 17,000 | $430k | 44.4% | Unusual | SEC |
| Feb 2, 2015 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 4,000 | $90k | 16.7% | Plan not stated | SEC |
| Jan 2, 2015 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 4,000 | $88k | 16.7% | Plan not stated | SEC |
| Dec 1, 2014 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 4,000 | $85k | 16.7% | Plan not stated | SEC |
| Nov 3, 2014 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 4,000 | $82k | 16.7% | Plan not stated | SEC |
| Oct 2, 2014 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 5,809 | $116k | 22.0% | Plan not stated | SEC |
| Sep 2, 2014 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 2,191 | $44k | 9.6% | Plan not stated | SEC |
| Aug 1, 2014 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 4,000 | $84k | 16.7% | Plan not stated | SEC |
| Jul 1, 2014 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 4,000 | $95k | 16.7% | Plan not stated | SEC |
| Jun 16, 2014 | OncoMed Pharmaceuticals Inc | EVP & Chief Scientific Officer | Form 4 sale | 4,000 | $98k | 16.7% | Plan not stated | SEC |